WEBINARS
Life Sciences Lunch Series: The Cost of Delayed Cancer Diagnoses
DATE
SPEAKERS
Dr. Tarah Ballinger
Assistant Professor of Clinical Medicine Indiana University School of Medicine
Dr. Christina Clarke Dur
Head of Epidemiology, Senior Director of Medical Affairs GRAIL
Bryan Hannon
Regional Government Relations Director American Cancer Society, Illinois Division
Kristin Jones
President and CEO Indiana Life Sciences AssociationSPEAKERS
Dr. Tarah Ballinger
Assistant Professor of Clinical Medicine Indiana University School of Medicine Dr. Christina Clarke Dur
Head of Epidemiology, Senior Director of Medical Affairs GRAIL Bryan Hannon
Regional Government Relations Director American Cancer Society, Illinois Division Kristin Jones
President and CEO Indiana Life Sciences AssociationAs a result of the pandemic, 2020 saw a large drop-off in the screening rates for many types of cancer. In general, cancer is easier to treat when identified in early stages and “missed” cancers may be larger or more advanced when ultimately detected. While the impact of the pandemic on overall cancer deaths will not be clear for many years, it has produced both reasons for concern and optimism.
Please join us as our panel discusses the impact of COVID-19 on cancer screenings, whether the trend is reversing, and how innovation – particularly around multi-cancer early detection – may help current and future patients.
Questions? Email Lindsay Hulliberger or call 312-214-5661.
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-11-14-13-11-27-495-6735f6fff42d6cc59c8ec5c1.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-11-11-22-02-38-042-67327efe31216b909e6ea644.jpg)
